Abstract
Background: Evidence has shown that Magnesium Sulphate (MgSo4) is the gold standard for treating severe pre-eclampsia and eclampsia (SPE/E), and calls for its widespread use at all levels of health service delivery, including the primary care level. Objective: To determine if administering loading dose of MgSo4 on pregnant women with severe preeclampsia and eclampsia at primary care level would improve maternal and fetal outcomes. Method: Two sets of Primary Health Care (PHC) facilities were identified; one served as experimental one and the other as control. The community health extension workers (CHEWs) and the community health officers (CHOs) at the experimental PHCs were trained to administer the loading dose of MgSo4 for patients with SPE/E, in addition to other supportive treatments, before making a referral while the control PHCs did not give MgSo4, and neither administered diazepam as an alternative or no anti-convulsant at all, before making a referral to higher centers. Patients from the experimental and control facilities were prospectively monitored for fetal and maternal outcomes, namely maternal and fetal deaths, and for toxic effects of MgSo4 in the experimental arm. Results: Of the 150 patients recruited, 82 (55%) were in the experimental group and 68 (45%) were in the control group. 90% of the patients in the experimental group defaulted after receiving the loading dose of MgSo4 while the remaining 10% completed the referral process. 44% of those in the control group completed the referral process. There were 3 maternal and 3 perinatal deaths, all in the control group. No adverse outcome (maternal or fetal death) or toxic effect was recorded among the recipients of MgSo4. Conclusion: This study suggests that lower-cadre health care professionals at PHCs can administer the loading dose of MgSo4 to SPE/E patients to improve maternal and fetal survival in critical states, without significant risk of adverse effects. However, the lack of compliance with referral processes remains a huge challenge.
Highlights
Hypertensive disorder in pregnancy, pre-eclampsia, is an obstetric complication which poses serious threat to lives and wellbeing of pregnant women and their babies
Program managers and policy-makers who are introducing task-shifting or task-sharing with MgSo4 in rural areas must be cognizance of this unhealthy phenomenon. This study addressed this counseling need from the beginning, failure to complete the referral process persisted, indicating the need for further community mobilization and community-level action which has been shown to be successful in the fight against post-partum hemorrhage in northern Nigeria [12]
This study suggests that with appropriate training and supervision, lower-cadre health care professionals can safely administer MgSo4 to treat severe pre-eclampsia and eclampsia without significant toxic effects in primary care settings in developing countries
Summary
Hypertensive disorder in pregnancy, pre-eclampsia, is an obstetric complication which poses serious threat to lives and wellbeing of pregnant women and their babies This pregnancy mal-adaptation does not show ethnic, racial or geographical predilection, with a global incidence uniformly around 10% [1], its progression to eclampsia occurs with increasing frequency among antenatal and parturient population in developing countries where antenatal care services are not accessible and/or are of poor quality [1]. Objective: To determine if administering loading dose of MgSo4 on pregnant women with severe preeclampsia and eclampsia at primary care level would improve maternal and fetal outcomes. 90% of the patients in the experimental group defaulted after receiving the loading dose of MgSo4 while the remaining 10% completed the referral process. Conclusion: This study suggests that lower-cadre health care professionals at PHCs can administer the loading dose of MgSo4 to SPE/E patients to improve maternal and fetal survival in critical states, without significant risk of adverse effects. The lack of compliance with referral processes remains a huge challenge
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
